Epiaortic Ultrasound to Prevent Stroke in Coronary Artery Bypass Grafting.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
01 2020
Historique:
received: 26 02 2019
revised: 26 05 2019
accepted: 20 06 2019
pubmed: 20 8 2019
medline: 24 4 2020
entrez: 18 8 2019
Statut: ppublish

Résumé

Epiaortic ultrasonography (EAU) is a valid imaging method to detect atherosclerotic changes of the ascending aorta and to guide surgical strategies for the prevention of cerebral embolism in patients undergoing isolated coronary artery bypass grafting (CABG). However, its use is not widespread. The impact of EAU on the outcome after isolated CABG was investigated in patients from the European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG) registry. A systematic review and meta-analysis of the literature was performed to substantiate the findings of this observational study. EAU was performed intraoperatively in 673 of 7241 patients (9.3%) from the E-CABG registry. In the overall series, the rates of stroke without and with aortic manipulation were 0.3% and 1.3%, respectively (P = .003). In 660 propensity score-matched pairs, EAU was associated with significantly lower risk of stroke (0.6% vs 2.6%, P = .007). A literature search yielded 5 studies fulfilling the inclusion criteria. These studies, along with the present one, included 11,496 patients, of whom 3026 (25.7%) underwent intraoperative EAU. Their rate of postoperative stroke was significantly lower than in patients not investigated with EAU (pooled rate, 0.6% vs 1.9%; risk ratio, 0.40; 95% confidence interval, 0.24-0.66; I Avoiding aortic manipulation is associated with the lowest risk of stroke in patients undergoing CABG. When manipulation of the ascending aorta is planned, EAU is effective in guiding the surgical strategy to reduce the risk for embolic stroke in these patients.

Sections du résumé

BACKGROUND
Epiaortic ultrasonography (EAU) is a valid imaging method to detect atherosclerotic changes of the ascending aorta and to guide surgical strategies for the prevention of cerebral embolism in patients undergoing isolated coronary artery bypass grafting (CABG). However, its use is not widespread.
METHODS
The impact of EAU on the outcome after isolated CABG was investigated in patients from the European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG) registry. A systematic review and meta-analysis of the literature was performed to substantiate the findings of this observational study.
RESULTS
EAU was performed intraoperatively in 673 of 7241 patients (9.3%) from the E-CABG registry. In the overall series, the rates of stroke without and with aortic manipulation were 0.3% and 1.3%, respectively (P = .003). In 660 propensity score-matched pairs, EAU was associated with significantly lower risk of stroke (0.6% vs 2.6%, P = .007). A literature search yielded 5 studies fulfilling the inclusion criteria. These studies, along with the present one, included 11,496 patients, of whom 3026 (25.7%) underwent intraoperative EAU. Their rate of postoperative stroke was significantly lower than in patients not investigated with EAU (pooled rate, 0.6% vs 1.9%; risk ratio, 0.40; 95% confidence interval, 0.24-0.66; I
CONCLUSIONS
Avoiding aortic manipulation is associated with the lowest risk of stroke in patients undergoing CABG. When manipulation of the ascending aorta is planned, EAU is effective in guiding the surgical strategy to reduce the risk for embolic stroke in these patients.

Identifiants

pubmed: 31421104
pii: S0003-4975(19)31181-6
doi: 10.1016/j.athoracsur.2019.06.078
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

294-301

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Fausto Biancari (F)

Heart Center, Turku University Hospital and Department of Surgery, University of Turku, Turku, Finland; Department of Surgery, University of Oulu, Oulu, Finland. Electronic address: faustobiancari@yahoo.it.

Francesco Santini (F)

Division of Cardiac Surgery, University of Genoa, Genoa, Italy.

Tuomas Tauriainen (T)

Department of Surgery, University of Oulu, Oulu, Finland.

Ciro Bancone (C)

Department of Cardiothoracic Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.

Vito G Ruggieri (VG)

Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France.

Andrea Perrotti (A)

Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France.

Riccardo Gherli (R)

Cardiac Surgery Unit, Department of Cardiovascular Sciences, S. Camillo-Forlanini Hospital, Rome, Italy.

Till Demal (T)

Hamburg University Heart Center, Hamburg, Germany.

Magnus Dalén (M)

Department of Molecular Medicine and Surgery and Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm; Sweden.

Giuseppe Santarpino (G)

Cardiovascular Center, Paracelsus Medical University, Nuremberg, Germany; Città di Lecce Hospital, GVM Care & Research, Lecce, Italy.

Antonino S Rubino (AS)

Department of Cardiothoracic Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.

Saverio Nardella (S)

Department of Cardiac Surgery, St Anna Hospital, Catanzaro, Italy.

Francesco Nicolini (F)

Division of Cardiac Surgery, University of Parma, Parma, Italy.

Marco Zanobini (M)

Department of Cardiac Surgery, Centro Cardiologico-Fondazione Monzino, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy.

Marisa De Feo (M)

Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France.

Francesco Onorati (F)

Division of Cardiovascular Surgery, Verona University Hospital, Verona, Italy.

Giovanni Mariscalco (G)

Department of Cardiovascular Sciences, Clinical Sciences Wing, Glenfield Hospital, University of Leicester, Leicester, United Kingdom.

Giuseppe Gatti (G)

Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH